On Thursday December 3, 2015, Camurus started its first day of trading on Nasdaq Stockholm. The share price increased considerably during the first day and Camurus is now the largest company in the biotechnology sector on Nasdaq Stockholm
The price of the Camurus share was set at SEK 57, but at closing time the share was noted at SEK 65,5, an increase of no less than 15,7 percent. The upturn meant that the market capitalization of Camurus was close to SEK 2,5 million at the end of the day. Today (January 2016) the market capitalization is about SEK 2,8 million.
Sandberg Development will remain the largest shareholder in Camurus and will hold appr. 54 percent of the total number of shares in the company.
Latest news
2018-12-07
Buvidal® Weekly and Buvidal® Monthly (CAM2038) approved in Australia as the first long-acting treatment of opioid dependence
Camurus announced today that the Australian Therapeutic Goods Administration (TGA) has approved the company’s lead p…